Gynositol

Gynositol is an oral **dietary supplement/nutraceutical** developed by Gynov for women with polycystic ovary syndrome and related reproductive-metabolic dysfunction, particularly women with polycystic ovaries who wish to become pregnant. It is a fixed combination of **myo-inositol + 5-methyltetrahydrofolate**, intended to replenish myo-inositol deficiency reported in PCOS and provide bioactive folate support. Its therapeutic rationale is primarily **insulin-sensitization and restoration of ovarian function**, with expected downstream effects on insulin resistance, menstrual cyclicity, ovulation, and oocyte quality; 5-methyltetrahydrofolate contributes folate supplementation rather than a distinct targeted pharmacologic mechanism. The product is marketed as a food for special medical purposes rather than a conventional pharmaceutical drug.

Brand names

Gynositol